www.fdanews.com/articles/73391-codexis-and-matrix-laboratories-enter-into-partnership
Codexis and Matrix Laboratories Enter Into Partnership
June 15, 2005
Codexis, a privately-held biosciences company, announced it has signed an agreement with Matrix Laboratories (Matrix), a leading provider of active pharmaceutical ingredients (APIs) to the global pharmaceutical industry, for the development and commercialization of the API for a high-value pharmaceutical product. Codexis will employ its proprietary pharmaceutical process re-engineering technology platform to develop a novel synthetic process for the product via a Codexis Thoroughbred biocatalyst.
()a href="http://www.drugnewswire.com/795/">DrugNewswire